STA
OGN icon

Summit Trail Advisors’s Organon & Co OGN Stock Holding History

Summit Trail Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Sell
35,494
-19,089
-35% -$144K ﹤0.01% 1367
2025
Q4 		$391K Buy
54,583
+31,944
+141% +$252K 0.01% 1148
2025
Q3 		$242K Buy
22,639
+4,021
+22% +$39.5K ﹤0.01% 1251
2025
Q2 		$180K Buy
18,618
+6,193
+50% +$63.9K ﹤0.01% 1069
2025
Q1 		$185K Buy
+12,425
New +$191K 0.01% 383

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Summit Trail Advisors's OGN Position: Q1 2026 in Review

Summit Trail Advisors reduced its Organon & Co (OGN) stake by 35% in Q1 2026, selling an estimated $144K and leaving 35,494 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Summit Trail Advisors first reported a position in OGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $391K in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Summit Trail Advisors held 35,494 shares of Organon & Co worth $213K as of Q1 2026.
  • Summit Trail Advisors sold 19,089 Organon & Co shares in Q1 2026, an estimated $144K.
  • Organon & Co made up ﹤0.01% of Summit Trail Advisors's portfolio in Q1 2026, its #1367 holding.
  • Summit Trail Advisors first reported a position in Organon & Co in Q1 2025 and has held it in 5 quarters since.
  • Summit Trail Advisors's Organon & Co position peaked at $391K in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.